glp-1 obesity drug news october 21 2025 Are you eligible? Medicare's new Bridge program will cover certain weight-loss drugs starting this week. But as of now, the program isn't permanent: http://www.wltx.com/article/news/nation-world/medicare-covering-glp-1- weight-loss-drugs-bridge The popularity of GLP-1 drugs

These include nausea, diarrhea, vomiting, and constipation

Effect of GLP-1 RAs on LDL-C, HDL-C, and TL levels Studies have shown contradictions regarding the effect of GLP-1 RAs on LDL-C levels in the body, specifically with liraglutide or exenatide

Target 0.7-0.8g per pound of body weight daily, distributed across 4-5 smaller meals

Although current evidence supports broad applicability across BMI, diabetes status, and fibrosis stages F2-F3, subgroup analyses suggest attenuated responses in non-obese patients and in certain ethnic groups (Hispanic patients in ESSENCE), emphasizing the need for precision medicine approaches incorporating anthropometric, genetic (e.g., PNPLA3, HSD17B13), and metabolic profiling

Walmart previously recorded stronger grocery sales when high inflation was driving wealthier shoppers to its stores

Each insurance company sets its policies and formularies, which can vary by state and specific plans within a state